Cargando…
Microphthalmia‐associated transcription factor in melanoma development and MAP‐kinase pathway targeted therapy
Malignant melanoma is a neoplasm of melanocytes, and the microphthalmia‐associated transcription factor (MITF) is essential for the existence of melanocytes. MITF's relevance for this cell lineage is maintained in melanoma, where it is an important regulator of survival and balances melanoma ce...
Autores principales: | Wellbrock, Claudia, Arozarena, Imanol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692100/ https://www.ncbi.nlm.nih.gov/pubmed/25818589 http://dx.doi.org/10.1111/pcmr.12370 |
Ejemplares similares
-
The Complexity of the ERK/MAP-Kinase Pathway and the Treatment of Melanoma Skin Cancer
por: Wellbrock, Claudia, et al.
Publicado: (2016) -
Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
por: Ferguson, Jennifer, et al.
Publicado: (2012) -
Targeting MITF in the tolerance-phase
por: Arozarena, Imanol, et al.
Publicado: (2016) -
Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth
por: Ferguson, Jennifer, et al.
Publicado: (2017) -
Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma
por: Smith, Michael P., et al.
Publicado: (2013)